ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Ex-ENT&A CEO Bob Glazer Joins Prosidio as Strategic Advisor

Robert (Bob) Glazer, former Chief Executive Officer of ENT and Allergy Associates (ENT&A), the nation's largest ENT group, has signed on as a strategic advisor.

WHITE PLAINS, NY, August 02, 2025 /24-7PressRelease/ -- Prosidio, the surgical-visualization company making premium endoscopy affordable for outpatient practices, today announced that Robert (Bob) Glazer, former Chief Executive Officer of ENT and Allergy Associates (ENT&A), the nation's largest ENT group, has signed on as a strategic advisor. Glazer's three-decade track record of building and scaling physician practices will help accelerate Prosidio's rollout of its suitcase-sized, chip-on-tip endoscopy platform.

"Bob understands the tightrope private practices walk between clinical excellence and capital budgets," said Jonathan Simmonds, MD, co-founder and CEO of Prosidio. "His insight into practice operations will be invaluable as we bring hospital-grade visualization to every exam room."

"I've followed Jonathan since his third-year residency at Tufts. His entrepreneurial drive, real-time surgical insight, and passion for technology are the forces behind Prosidio's chip-on-tip video scope, premium imaging that private practices can finally afford," said Bob Glazer.

Having witnessed Prosidio compress an entire endoscopy tower into a suitcase-sized 4K platform, Glazer says the chance to help private practices adopt the technology "was too compelling to pass up." He will guide the company's commercial strategy and distribution partnerships.

"Prosidio's all-in-one scope nails it for private practices, premium image quality at a price that actually makes sense. I know my colleagues in the otolaryngology space are looking for a state-of-the-art alternative, and I'm excited to help spread the word," Glazer added.

During his tenure at ENT&A, Glazer grew the group from 40 to more than 300 physicians across 60 locations, pioneering many of the operational playbooks now common in private ENT. As Prosidio's advisor, he will guide market expansion and physician-practice adoption. The collaboration underscores Prosidio's commitment to empowering outpatient specialists with cutting-edge tools that drive growth while keeping care affordable.

Prosidio is a privately held medical-device company headquartered in Port Chester, New York. We engineer ultra-compact 4K endoscopy and imaging systems that give surgeons the illumination, resolution, and ergonomics of top-tier hospital towers in a suitcase-sized footprint. By pairing optics designed with ENT and skull-base specialists with a cost-controlled supply chain, Prosidio makes advanced surgical visualization practical everywhere, from community clinics to mission theaters. Our mission is simple: to put world-class sight in every surgeon's hands, everywhere.

---
Press release service and press release distribution provided by https://www.24-7pressrelease.com
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.